Medical Research News

RSS

Professional rugby participation may be linked with structural changes in the brain

Participation in elite adult rugby may be associated with changes in brain structure.

22 Jul 2021

SARS-CoV-2 proteins manipulate autophagy

The ongoing coronavirus pandemic (COVID-19) has claimed more than 4.1 million lives worldwide. This pandemic is caused by a novel single-stranded RNA virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first reported in 2019 in Wuhan, China. The rapid spread of this virus is attributed to its high infectiousness and its ability to escape and counteract host immune responses, e.g., autophagy.

22 Jul 2021

Experts call for immediate action to ensure physical activity is built into everyday lives

Not enough progress has been made to address physical inactivity worldwide, with adolescents and people living with disabilities (PLWD) among the least likely populations to have the support needed to meet the World Health Organization (WHO)'s physical activity guidelines.

22 Jul 2021

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.

22 Jul 2021

Study finds strong interconnection between toxic pollution and climate risks to human health

For more than 30 years, scientists on the U.N.'s Intergovernmental Panel on Climate Change have focused on human-induced climate change.

21 Jul 2021

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Researchers at Weill Cornell Medicine and NewYork-Presbyterian in New York have discovered that injecting mice with pulmonary endothelial cells-the cells that line the walls of blood vessels in the lung-can reverse the symptoms of emphysema.

21 Jul 2021

Study lays out challenges of achieving equity in communication for diverse patients at hospital discharge

A new study by research, quality improvement and health equity experts at Massachusetts General Hospital in The American Journal of Managed Care lays out the challenges of achieving equity for diverse patients in communication at hospital discharge.

21 Jul 2021

SARS-CoV-2 can be transmitted by cats

Researchers in The Netherlands have warned that domestic cats may play a role in the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

21 Jul 2021

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

21 Jul 2021

Study evaluates ICU workers' mental health during the COVID-19 pandemic

A high proportion of staff working in intensive care units during the COVID-19 pandemic have experienced mental health conditions, according to a new study.

21 Jul 2021

Longer school lunch breaks can spur kids to eat more fruit and vegetables

When kids sit down to eat lunch at school, fruits and vegetables may not be their first choice. But with more time at the lunch table, they are more likely to pick up those healthy foods.

21 Jul 2021

Study evaluates physical activity and sedentary behavior in relation to OSA risk

Being more physically active and spending fewer hours per day sitting watching TV is linked to a substantially lower risk of developing obstructive sleep apnea (OSA), according to new research published in the European Respiratory Journal

21 Jul 2021

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Researchers in the United States have conducted a study showing that while variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can compromise the effectiveness of single therapeutic antibodies at preventing severe coronavirus disease 2019 (COVID-19), many combination antibody products remain potent against the variants.

21 Jul 2021

Medical Research News

Professional rugby participation may be linked with structural changes in the brain

SARS-CoV-2 proteins manipulate autophagy

Experts call for immediate action to ensure physical activity is built into everyday lives

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

Study finds strong interconnection between toxic pollution and climate risks to human health

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Study lays out challenges of achieving equity in communication for diverse patients at hospital discharge

SARS-CoV-2 can be transmitted by cats

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Study evaluates ICU workers' mental health during the COVID-19 pandemic

Longer school lunch breaks can spur kids to eat more fruit and vegetables

Study evaluates physical activity and sedentary behavior in relation to OSA risk

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Older people appear to have diminished antibody response after COVID-19 vaccination

Existing drug may be effective in treating COVID-19

Global consortium publishes findings on all-cause mortality during COVID-19 pandemic in 22 countries

Researchers use information theory to monitor resistance mechanisms to targeted cancer therapy

New technology can pave the way for development of long-acting drugs

U.S. sees sharp decrease in life expectancy largely due to COVID-19 pandemic, CDC says

Pilot trial assesses sensory stimulation as a treatment for improving mobility in stroke survivors

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News